Professor Marcel Levi
Dr Claire Roddie
Professor Gary Royle
Professor Daniel Hochhauser
Professor Mariana Mazzucato
Rethinking Cancer | UCL Cancer Domain Symposium
Monday 13 May 2019
The cancer treatment revolution and how we afford it?
Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology.
This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.
653
6/4/2019
Dr Claire Roddie
Consultant Haematologist;
Honorary Senior Lecturer in Haematology, UCL
Rethinking Cancer | UCL Cancer Domain Symposium
Monday 13 May 2019
The cancer treatment revolution and how we afford it?
Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology.
This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.
853
6/4/2019
Professor Marcel Levi
Chief Executive, UCLH and Professor of Medicine, UCL
Rethinking Cancer | UCL Cancer Domain Symposium
Monday 13 May 2019
The cancer treatment revolution and how we afford it?
Cancer remains one of the major causes of morbidity and premature death worldwide; one in two people in the UK born after 1960 will be diagnosed with some form of cancer during their lifetime. UCL has a proud track record in addressing the societal, technical, and health challenges of cancer and in exploring its underling biology.
This symposium, invited our broad community to assemble for the first time at scale to consider challenges and opportunities in cancer research, prevention and treatment, from biological, clinical, technical, economic and societal perspectives.
648
6/4/2019